Evaluation of a long-acting converting enzyme inhibitor (Enalapril) for the treatment of chronic congestive heart failure
- 1 April 1983
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 1 (4) , 1154-1159
- https://doi.org/10.1016/s0735-1097(83)80119-3
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- The effect of captopril on postural hemodynamics and autonomic responses in chronic heart failureAmerican Heart Journal, 1982
- Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failureAmerican Heart Journal, 1982
- Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: effects of acute and long-term converting-enzyme inhibition.Circulation, 1982
- The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: Response to specific inhibitors (prazosin and captopril)The American Journal of Cardiology, 1982
- Captopril: Clinical Pharmacology and Benefit‐to‐Risk Ratio in Hypertension and Congestive Heart FailurePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1982
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.Circulation, 1980
- Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation, 1980
- The role of renin and aldosterone in the salt retention of edemaThe American Journal of Medicine, 1977
- Hormones and the Pathogenesis of Congestive Heart Failure:Vasopressin, Aldosterone, and Angiotensin IICirculation, 1962